Literature DB >> 15365135

Clinical recognition of allodynia in migraine.

Ninan T Mathew1, Jayasree Kailasam, Tad Seifert.   

Abstract

BACKGROUND: Allodynia, a manifestation of central sensitization, is not routinely evaluated during clinical interviews even though its therapeutic implications are known.
OBJECTIVE: To assess the frequency and manifestations of allodynia in a clinic-based migraine population.
METHODS: A total of 295 consecutive International Headache Society migraine patients were evaluated using a semistructured questionnaire.
RESULTS: A total of 157 (53.3%) reported allodynia. A total of 133 (84.7% of those with allodynia) had cephalic, 54 (18%) had both cephalic and extracephalic, and 24 (8.5%) exhibited pure extracephalic allodynia. Prominent scalp symptoms were sensitivity to touch; soreness or tenderness; difficulty brushing, combing, or washing hair; difficulty lying with head resting on the side of allodynia; and circumscribed area of hypersensitivity and tenderness. Scalp allodynia was ipsilateral to predominant headache side in the majority and occurred at the height of headache. Extracephalic allodynia of the upper extremities occurred in 72, toes in 6. Truncal allodynia occurred in some. Age range and age at onset of migraine were identical in allodynic and non-allodynic patients. Patients with allodynia were on an average 8 years older than non-allodynic patients (p < 0.05). Correlation was found between the duration of illness as well as frequency of migraine attacks and allodynia. Frequent migraineurs exhibited prolonged allodynia.
CONCLUSIONS: Clinically detectable allodynia, which occurs with high frequency in migraineurs, should become part of the clinical evaluation because of its implications in early treatment with triptans, recurrence of headache, consistency of response to triptans, and development of chronicity of migraine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365135     DOI: 10.1212/01.wnl.0000137107.27585.f7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  56 in total

1.  Clinical significance of sensory hypersensitivities in migraine patients: does allodynia have a priority on it?

Authors:  Jong-Geun Seo; Sung-Pa Park
Journal:  Neurol Sci       Date:  2018-12-01       Impact factor: 3.307

2.  Identifying cutaneous allodynia in chronic migraine using a practical clinical method.

Authors:  A Ashkenazi; M Sholtzow; J W Shaw; R Burstein; W B Young
Journal:  Cephalalgia       Date:  2007-02       Impact factor: 6.292

Review 3.  Sensitization, glutamate, and the link between migraine and fibromyalgia.

Authors:  Paola Sarchielli; Massimiliano Di Filippo; Katiuscia Nardi; Paolo Calabresi
Journal:  Curr Pain Headache Rep       Date:  2007-10

4.  Intercepting migraine: results of early therapy with nonspecific and migraine-specific agents.

Authors:  Robert Kaniecki
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.598

5.  Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course.

Authors:  Ilya Kister; A B Caminero; T S Monteith; A Soliman; T E Bacon; J H Bacon; J T Kalina; M Inglese; J Herbert; R B Lipton
Journal:  J Headache Pain       Date:  2010-07-13       Impact factor: 7.277

Review 6.  Multisensory integration in migraine.

Authors:  Todd J Schwedt
Journal:  Curr Opin Neurol       Date:  2013-06       Impact factor: 5.710

Review 7.  Shedding light on photophobia.

Authors:  Kathleen B Digre; K C Brennan
Journal:  J Neuroophthalmol       Date:  2012-03       Impact factor: 3.042

8.  [Duration of migraine disease correlates with amplitude and habituation of event-related potentials].

Authors:  P Kropp; U Linstedt; W-D Gerber
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

9.  Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

Authors:  Ram Kandasamy; Cole T Dawson; Rebecca M Craft; Michael M Morgan
Journal:  Eur J Pharmacol       Date:  2017-10-28       Impact factor: 4.432

10.  Genetic enhancement of calcitonin gene-related Peptide-induced central sensitization to mechanical stimuli in mice.

Authors:  Blanca Marquez de Prado; Donna L Hammond; Andrew F Russo
Journal:  J Pain       Date:  2009-07-22       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.